| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 12.444 | 42.450 | 39.600 | 20.214 | 39.055 | 122.432 | 3.623 | 3.722 | 7.483 | - |
| Total Income - EUR | 14.864 | 43.132 | 41.063 | 20.975 | 39.950 | 124.083 | 5.025 | 5.680 | 7.567 | - |
| Total Expenses - EUR | 4.236 | 3.510 | 4.418 | 3.008 | 2.361 | 10.090 | 4.064 | 5.201 | 11.463 | - |
| Gross Profit/Loss - EUR | 10.628 | 39.622 | 36.645 | 17.966 | 37.589 | 113.993 | 960 | 478 | -3.896 | - |
| Net Profit/Loss - EUR | 10.242 | 38.349 | 35.432 | 17.360 | 36.405 | 110.287 | 838 | 369 | -3.971 | - |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | - |
Check the financial reports for the company - Armin Schmidt Pharmaceutical S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 1.133 | 1.121 | 1.102 | 2.986 | 2.928 | 2.872 | 7.784 | 6.250 | 4.677 | - |
| Current Assets | 52.582 | 43.504 | 40.029 | 22.866 | 41.151 | 117.570 | 110.496 | 29.998 | 25.541 | - |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Receivables | 49.529 | 40.532 | 38.919 | 22.748 | 40.734 | 52.074 | 90.392 | 19.186 | 19.555 | - |
| Cash | 3.053 | 2.972 | 1.110 | 119 | 418 | 65.496 | 20.104 | 10.812 | 5.986 | - |
| Shareholders Funds | 49.087 | 38.402 | 35.485 | 17.412 | 36.456 | 110.337 | 108.728 | 2.445 | -1.533 | - |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | - |
| Debts | 4.627 | 6.223 | 5.646 | 8.440 | 7.624 | 10.105 | 9.551 | 33.803 | 31.752 | - |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "7320 - 7320" | |||||||||
| CAEN Financial Year |
7320
|
|||||||||
Comments - Armin Schmidt Pharmaceutical S.r.l.